期刊文献+

特发性血小板减少性紫癜患者IgG酶切片段F(ab′)_2的免疫活性及其对血小板聚集功能的影响 被引量:1

The immunoreactivity of IgG and its fragments from ITP patients and their effects on platelet aggregation function
原文传递
导出
摘要 目的制备特发性血小板减少性紫癜(ITP)患者血浆 IgG 及其酶切片段,探讨其与血小板 GPⅡb/Ⅲa 和(或)GP Ⅰb/Ⅸ结合的免疫活性及其对正常人血板小板聚集功能的影响。方法用改良 MAIPA 法和比浊法血小板聚集试验筛选出自身抗体阳性并且能抑制血小板聚集的患者,用蛋白 A柱纯化其血浆 IgG 抗体并用胃蛋白酶制备 F(ab′)_2片段,改良单克隆抗体俘获血小板抗原技术(MAIPA)检测完整抗体及其酶切片段与血小板膜糖蛋白的结合活性;比浊法血小板聚集试验对比观察 ITP 患者血浆、纯化的 IgG 抗体及其酶切片段对正常人血小板聚集功能的影响。结果①68例慢性ITP 患者中,34例(53.6%)血浆中抗 CPⅡb/Ⅲa 和(或)CPⅠb/Ⅸ自身抗体阳性,其中5例(14.7%)明显抑制了二磷酸腺甘(ADP)或瑞斯托霉素对血小板聚集的诱导作用;②用蛋白 A 柱结合蛋白酶酶切成功获得了纯化的 IgG 及 F(ab′)_2片段;③患者纯化的 IgG 及 F(ab′)_2片段均具有抗 GPⅡb/Ⅲa 或GP Ⅰb/Ⅸ活性,但去除 IgG 的血浆丧失了与 GPⅡb/Ⅲa 或 CP Ⅰb/Ⅸ的结合活性;④2例患者纯化的IgG 及其 F(ab′)_2片段抑制 ADP 诱导的血小板聚集。结论 F(ab′)_2片段是 IgG 自身抗体的功能片段,它不但保留了良好的抗原结合活性并可抑制血小板聚集功能,其抑制聚集作用呈剂量依赖性。 Objective To prepare ITP plasma IgG and its F (ab')2 fragments and investigate their immunoreactivity to platelet GP Ⅱ b/Ⅲ a and/or GP Ⅰ b/Ⅸ and their effects on platelet aggregation function. Methods The ITP patients having inhibitory autoantibody to the platelet aggregation were selected by modified MAIPA and platelet aggregation test with turbidomitry. Plasma IgG and its F(ab') 2 fragments were prepared by streptococcal protein A affinity column and pepsin digestion. The immunoreactivity and the effects on platelet aggregation function of the whole antibody and its fragments were detected by modified MAIPA and platelet aggregation test, respectively. Results ①Anti-platelet GP Ⅱ b/Ⅲ a and/or GP Ⅰb/Ⅸ autoantibodies were detected in 34 of 68 (53.6%) ITP patients' plasmas and that from 5 patients significantly inhibited the platelet aggregation induced by ADP or ristocetin. ②By using protein A column combined with protease digestion, pure IgG and its F (ab')2 fragments were successfully obtained. ③The purified IgG and its F(ab') 2 fragments retained the ability to bind to their respective glycoproteins and inhibited the platelet aggregation function, whereas the IgG depleted plasma lost the ability of binding to the platelet GPs. Conclusions F(ab') 2 fragment of the IgG antibody is a functional fragment, which not only has the binding ability to the platelet GPs but also inhibits the platelet aggregation function in a dose-dependent manner.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2006年第3期158-161,共4页 Chinese Journal of Hematology
基金 国家自然科学基金(30470742 30300312) 山东省自然科学基金(Y2003C06)
关键词 紫癜 血小板减少性 特发性 抗体 免疫活性 血小板聚集 Purpura, thrombocytopenic, idiopathic Antibody Immunoreactivity Platelet
  • 相关文献

参考文献6

  • 1Goto S.New therapy with monoclonal antibodies-abciximab,chimeric anti-GP Ⅱb/ Ⅲ a antibody.Nippon Rinsho,2002,60:492-496.
  • 2Kageyama S,Matsushita J,Yamamoto H.Effect of a humanized monoclonal antibody to von Willebrand factor in a canine model of coronary arterial thrombosis.Eur J Pharmacol,2002,443:143-149.
  • 3Olsson A,Andersson PO,Tengborn L,et al.Serum from patients with chronic idiopathic thrombocytopenic purpura frequently affect the platelet function.Thromb Res,2002,107:135-139.
  • 4Hou M,Stockelberg D,Kutti J,et al.Glycoprotein Ⅱ b/ Ⅲ a autoantigenic repertoire in chronic idiopathic thrombocytopenic purpura.Br J Haematol,1995,91:971-975.
  • 5侯明,石艳,彭军,李蔚,马道新,张茂宏.慢性特发性血小板减少性紫癜自身抗体克隆性分析[J].中华内科杂志,2004,43(2):87-89. 被引量:8
  • 6冀学斌,侯明,马道新,李丽珍,彭军,王琳.人源化抗血小板膜糖蛋白Ⅱb/Ⅲa抗体库的构建及临床价值[J].中华内科杂志,2005,44(4):293-296. 被引量:2

二级参考文献14

  • 1Olsson A, Andersson PO, Tengborn L, et al. Serum from patients with chronic idiopathic thrombocytopenic purpura frequently affect the platelet function. Thromb Res, 2002,107: 135-139.
  • 2Welschof M, Terness P, Kolbinger F, et al. Amino acid sequence based PCR primers for amplification of rearranged human heavy and light chain immunoglobulin variable region genes. J Immunol Methods, 1995,179:203-214.
  • 3Boehlem F, Bulla O, de Moerloose P, et al. Evaluation of a new antigen capture ELISA for detection and characterization of platelet alloantibodies. Thromb Res, 1998,92:27-32.
  • 4Goto S. New therapy with monoclonal antibodies-abciximab, chimeric anti- GPⅡb/Ⅲa antibody. Nippon Rinsho, 2002,60:492-496.
  • 5Grodzicky T, Bussel JB, Elkon KB, et al. Anti-platelet antibodies associated with the Canale-Smith syndrome bind to the same platelet glycoprotein complexes as those of idiopathic thrombocytopenic purprua patients. Clin Exp Immunol, 2002,127:289-292.
  • 6He R;Reid DM;Jones CE.Spectrum of Ig classes, specificies, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpure,1994.
  • 7van der Harst D;de Jong D;Limpens J.Clonal B-cell populations in patients with idiopathic thrombocytopenic purpura,1990.
  • 8Christie DJ;Sauro SC;Fairbanks KD.Detection of clonal platelet antibodies in immunologically-mediated thrombocytopenias: association with circulating clonal/oligoclonal B cells[J],1993.
  • 9Stockelberg D;Hou M;Jacobsson S.Light-chain restricted antibodies in chronic idiopathic thrombocytopenic purpura,but no evidence for circulating clonal B-lymphocytes[J],1996.
  • 10McMillan R;Lopez Dee J;Bowditch R.Clonal restriction of platelet-associated anti-GPⅡb/Ⅲa autoantibodies in patients with chronic ITP,2001.

共引文献8

同被引文献6

  • 1崔宇杰,董宁征,庞爱明,白霞,阮长耿.人源性抗血小板膜糖蛋白IIb/IIIa Fab噬菌体抗体库的构建[J].细胞与分子免疫学杂志,2006,22(2):200-201. 被引量:2
  • 2Shinya G. New therapy with monoclonal antibodies-abeiximab, chimeric anti-GP Ⅱ b/Ⅲ a antibody [ J ]. Nippon Rinsho, 2002, 60 (3) : 492 - 496.
  • 3Coller BS. Anti-GP Ⅱb/Ⅲ a drugs : current strategies and future directions[J]. Thromb Haemost, 2001, 86(1 ): 27-43.
  • 4Kim S, Jang M, Ahn H, et al. Selection of an affinity-matured anti body against a defined epitope by phage display of an immune antibody library [J]. J Immurtol Methods, 2008, 329 ( 1 - 2 ) : 176 - 183.
  • 5Tornetta M, Fisher D, O'Neil K, et al. Isolation of human anti-idiotypic antibodies by phage display for clinical immune response assays [J]. J lmmunol Methods, 2007, 328 ( 1 - 2 ) : 34 - 44.
  • 6Grodzicky T, Bussel JB, Elkon KB, et al. Anti-platelet antibodies associated with the Canale-Smith syndrome bind to the same platelet glycoprotein complexes as those of idiopathic thrombocytopenic purpura patients[J]. Clin Exp Immunol, 2002, 127 : 289 - 292.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部